TrialMedical oncology (Northwood, London, England)2020

Phase II prospective trial "Give Me Five" short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion: the impact of toxicity on quality of life (AIRC IG-13218).

Giulia Marvaso et al.PubMed ↗Publisher ↗

No numbers read from the abstract.